Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan, Fludarabine, and Clofarabine in Advanced Refractory AML, MDS, and CML
NCT00469014Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2006
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), Chronic Myeloid Leukemia (CML), sponsored by University of Texas MD Anderson Cancer Center. Started Sep 2006; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)Chronic Myeloid Leukemia (CML)
Beyond the preview
Go deeper on NCT00469014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469014.